FindTrial
Sign In

The effects of transcutaneous auricular vagus nerve stimulation on postural instability in patients with Parkinson's disease

The effects of transcutaneous auricular vagus nerve stimulation on postural instability in patients with Parkinson's disease - Transcutaneous auricular vagus nerve stimulation for postural instability in Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052862
Enrollment
50
Registered
2023-11-22
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Transcutaneous auricular vagus nerve stimulation Sham stimulation

Sponsors

Kio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Hoehn & Yahr stage 1-4 2)Individuals capable of standing and walking without physical or personal assistance 3)stable antiparkinsonian medication during at least three weeks

Exclusion criteria

Exclusion criteria: 1)Coexistence of Neurological Disorders Other Than Parkinson's Disease 2)Deep Brain Stimulation Therapy 3)Metallic Substances in the Body 4)Decline in Cognitive Function 5)History of Cardiovascular Disease 6)Orthostatic Hypotension 7)Vagus Nerve Reflex

Design outcomes

Primary

MeasureTime frame
Outcomes on postural instability during standing and walking—

Secondary

MeasureTime frame
Motor symptoms, non-motor symptoms—

Countries

Japan

Contacts

Public ContactYohei Okada

Kio University Graduate School of Health Sciences

y.okada@kio.ac.jp+81-745-54-1601

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026